1 | concomitant | 5,409 |
2 | concurrent | 3,733 |
3 | coexistent | 147 |
4 | nonstatin | 48 |
5 | prestroke | 46 |
6 | co-existent | 18 |
7 | nonchronic | 17 |
8 | concomittant | 14 |
9 | bicarbonate-buffered | 13 |
10 | ooh | 13 |
11 | cortisol-induced | 9 |
12 | ampt-induced | 7 |
13 | high-ferritin | 6 |
14 | overusing | 6 |
15 | nonmethotrexate | 5 |
16 | vaser-assisted | 5 |
17 | leathery | 4 |
18 | risp+ | 4 |
19 | 4/0 | 3 |
20 | clinical-reminder | 3 |
21 | concurrent/consolidation | 3 |
22 | guidelines-recommended | 3 |
23 | luteal-phase-gnrh-a | 3 |
24 | quikclot® | 3 |
25 | -cost | 2 |
26 | antigen-responsive | 2 |
27 | calvet | 2 |
28 | decentralising | 2 |
29 | inotrope-based | 2 |
30 | intragestational | 2 |
31 | less-than-satisfactory | 2 |
32 | mvp-based | 2 |
33 | naloxone-sensitive | 2 |
34 | non-antimanic | 2 |
35 | non-sanad | 2 |
36 | postalbuterol | 2 |
37 | preeclampsia-associated | 2 |
38 | temozolamide | 2 |
39 | terrorism-related | 2 |
40 | uncertain/involved | 2 |
41 | weight-adapted | 2 |
42 | 'slow-acting | 1 |
43 | 40℃± | 1 |
44 | anodal-excitatory | 1 |
45 | brachytherapy-based | 1 |
46 | diagnotic | 1 |
47 | endobrochial | 1 |
48 | energy-assisted | 1 |
49 | fludarabine-rituximab-based | 1 |
50 | gamma-ii | 1 |
51 | modified-volume | 1 |
52 | non-irinotecan-based | 1 |
53 | pfannestiel | 1 |
54 | post-sifalimumab | 1 |
55 | radiosurgery/stereotactic | 1 |
56 | serotenergic | 1 |
57 | systemic/ocular | 1 |
58 | tp-r. | 1 |
1 | 'slow-acting | 1 |
2 | -cost | 2 |
3 | 4/0 | 3 |
4 | 40℃± | 1 |
5 | ampt-induced | 7 |
6 | anodal-excitatory | 1 |
7 | antigen-responsive | 2 |
8 | bicarbonate-buffered | 13 |
9 | brachytherapy-based | 1 |
10 | calvet | 2 |
11 | clinical-reminder | 3 |
12 | co-existent | 18 |
13 | coexistent | 147 |
14 | concomitant | 5,409 |
15 | concomittant | 14 |
16 | concurrent | 3,733 |
17 | concurrent/consolidation | 3 |
18 | cortisol-induced | 9 |
19 | decentralising | 2 |
20 | diagnotic | 1 |
21 | endobrochial | 1 |
22 | energy-assisted | 1 |
23 | fludarabine-rituximab-based | 1 |
24 | gamma-ii | 1 |
25 | guidelines-recommended | 3 |
26 | high-ferritin | 6 |
27 | inotrope-based | 2 |
28 | intragestational | 2 |
29 | leathery | 4 |
30 | less-than-satisfactory | 2 |
31 | luteal-phase-gnrh-a | 3 |
32 | modified-volume | 1 |
33 | mvp-based | 2 |
34 | naloxone-sensitive | 2 |
35 | non-antimanic | 2 |
36 | non-irinotecan-based | 1 |
37 | non-sanad | 2 |
38 | nonchronic | 17 |
39 | nonmethotrexate | 5 |
40 | nonstatin | 48 |
41 | ooh | 13 |
42 | overusing | 6 |
43 | pfannestiel | 1 |
44 | post-sifalimumab | 1 |
45 | postalbuterol | 2 |
46 | preeclampsia-associated | 2 |
47 | prestroke | 46 |
48 | quikclot® | 3 |
49 | radiosurgery/stereotactic | 1 |
50 | risp+ | 4 |
51 | serotenergic | 1 |
52 | systemic/ocular | 1 |
53 | temozolamide | 2 |
54 | terrorism-related | 2 |
55 | tp-r. | 1 |
56 | uncertain/involved | 2 |
57 | vaser-assisted | 5 |
58 | weight-adapted | 2 |
1 | risp+ | 4 |
2 | tp-r. | 1 |
3 | 4/0 | 3 |
4 | luteal-phase-gnrh-a | 3 |
5 | post-sifalimumab | 1 |
6 | serotenergic | 1 |
7 | non-antimanic | 2 |
8 | nonchronic | 17 |
9 | radiosurgery/stereotactic | 1 |
10 | diagnotic | 1 |
11 | non-sanad | 2 |
12 | cortisol-induced | 9 |
13 | ampt-induced | 7 |
14 | guidelines-recommended | 3 |
15 | bicarbonate-buffered | 13 |
16 | fludarabine-rituximab-based | 1 |
17 | inotrope-based | 2 |
18 | non-irinotecan-based | 1 |
19 | mvp-based | 2 |
20 | brachytherapy-based | 1 |
21 | preeclampsia-associated | 2 |
22 | terrorism-related | 2 |
23 | weight-adapted | 2 |
24 | vaser-assisted | 5 |
25 | energy-assisted | 1 |
26 | uncertain/involved | 2 |
27 | temozolamide | 2 |
28 | prestroke | 46 |
29 | modified-volume | 1 |
30 | nonmethotrexate | 5 |
31 | antigen-responsive | 2 |
32 | naloxone-sensitive | 2 |
33 | decentralising | 2 |
34 | overusing | 6 |
35 | 'slow-acting | 1 |
36 | ooh | 13 |
37 | gamma-ii | 1 |
38 | endobrochial | 1 |
39 | intragestational | 2 |
40 | pfannestiel | 1 |
41 | postalbuterol | 2 |
42 | nonstatin | 48 |
43 | high-ferritin | 6 |
44 | concurrent/consolidation | 3 |
45 | systemic/ocular | 1 |
46 | clinical-reminder | 3 |
47 | calvet | 2 |
48 | concomitant | 5,409 |
49 | concomittant | 14 |
50 | concurrent | 3,733 |
51 | co-existent | 18 |
52 | coexistent | 147 |
53 | -cost | 2 |
54 | leathery | 4 |
55 | anodal-excitatory | 1 |
56 | less-than-satisfactory | 2 |
57 | quikclot® | 3 |
58 | 40℃± | 1 |